NCT04803123 2023-12-21
Window Trial to Evaluate Molecular Response to PI3K Inhibition With Copanlisib in r/r Adult B-cell ALL
Duke University
Phase EARLY_PHASE1 Terminated
Duke University
Rutgers, The State University of New Jersey
Dana-Farber Cancer Institute